{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:40:09Z","timestamp":1751359209944,"version":"3.41.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Priority Union\u00a0Foundation of Yunnan Provincial Science and Technology Department and Kunming Medical University","award":["202201AY070001-070","202001AY070001-145"],"award-info":[{"award-number":["202201AY070001-070","202001AY070001-145"]}]},{"name":"The Clinical Key Specialty Project in Pathology of Yunnan Province","award":["300061"],"award-info":[{"award-number":["300061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04031-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:26:56Z","timestamp":1751354816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioinformatics identification of key microRNA-correlated genes associated with hepatocellular carcinoma heterogeneity and prognosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Guomiao","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"4031_CR1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pineros M, Znaor A, et al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156:1336\u201346.","journal-title":"Int J Cancer"},{"key":"4031_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47\u201353.","journal-title":"J Natl Cancer Cent"},{"key":"4031_CR3","doi-asserted-by":"crossref","unstructured":"Tan DJH, Wong C, Ng CH, Poh CW, Jain SR, Huang DQ et al. A Meta-Analysis on the rate of hepatocellular carcinoma recurrence after liver transplant and associations to etiology, Alpha-Fetoprotein, income and ethnicity. J Clin Med. 2021;10.","DOI":"10.3390\/jcm10020238"},{"key":"4031_CR4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jhep.2024.06.018","volume":"81","author":"C Fuster-Anglada","year":"2024","unstructured":"Fuster-Anglada C, Mauro E, Ferrer-Fabrega J, Caballol B, Sanduzzi-Zamparelli M, Bruix J, et al. Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection. J Hepatol. 2024;81:995\u20131004.","journal-title":"J Hepatol"},{"key":"4031_CR5","doi-asserted-by":"crossref","unstructured":"Attia AM, Rezaee-Zavareh MS, Hwang SY, Kim N, Adetyan H, Yalda T et al. Novel biomarkers for early detection of hepatocellular carcinoma. Diagnostics (Basel). 2024;14.","DOI":"10.3390\/diagnostics14202278"},{"key":"4031_CR6","doi-asserted-by":"crossref","unstructured":"Song G, Yu X, Shi H, Sun B, Amateau S. MiRNAs in HCC, pathogenesis, and targets. Hepatology. 2024.","DOI":"10.1097\/HEP.0000000000001177"},{"key":"4031_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-025-03391-x","volume":"44","author":"MTD Martino","year":"2025","unstructured":"Martino MTD, Tagliaferri P, Tassone P. MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications. J Exp Clin Cancer Res. 2025;44:126.","journal-title":"J Exp Clin Cancer Res"},{"key":"4031_CR8","doi-asserted-by":"crossref","unstructured":"Menon A, Abd-Aziz N, Khalid K, Poh CL, Naidu R. MiRNA: A promising therapeutic target in Cancer. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms231911502"},{"key":"4031_CR9","doi-asserted-by":"publisher","first-page":"107299","DOI":"10.1016\/j.phrs.2024.107299","volume":"206","author":"J Li","year":"2024","unstructured":"Li J, Zhang Y, Fu T, Xing G, Tong Y. Advancing cancer therapy: the role of MicroRNA in clinical applications. Pharmacol Res. 2024;206:107299.","journal-title":"Pharmacol Res"},{"key":"4031_CR10","first-page":"9963096","volume":"2022","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang H, Han X, Xing X. Bioinformatics methods reveal the biomarkers and the miRNA-mRNA network in hepatocellular carcinoma. J Healthc Eng. 2022;2022:9963096.","journal-title":"J Healthc Eng"},{"key":"4031_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1049\/iet-syb.2020.0061","volume":"14","author":"D Zhou","year":"2020","unstructured":"Zhou D, Dong L, Yang L, Ma Q, Liu F, Li Y, et al. Identification and analysis of circRNA-miRNA-mRNA regulatory network in hepatocellular carcinoma. IET Syst Biol. 2020;14:391\u20138.","journal-title":"IET Syst Biol"},{"key":"4031_CR12","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. MiRDB: an online database for prediction of functional MicroRNA targets. Nucleic Acids Res. 2020;48:D127\u201331.","journal-title":"Nucleic Acids Res"},{"key":"4031_CR13","doi-asserted-by":"publisher","first-page":"D93","DOI":"10.1093\/nar\/gkab1036","volume":"50","author":"Y Chen","year":"2022","unstructured":"Chen Y, Yao L, Tang Y, Jhong JH, Wan J, Chang J, et al. CircNet 2.0: an updated database for exploring circular RNA regulatory networks in cancers. Nucleic Acids Res. 2022;50:D93\u2013101.","journal-title":"Nucleic Acids Res"},{"key":"4031_CR14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12885-020-06869-3","volume":"20","author":"E Gu","year":"2020","unstructured":"Gu E, Song W, Liu A, Wang H. SCDb: an integrated database of stomach cancer. BMC Cancer. 2020;20:490.","journal-title":"BMC Cancer"},{"key":"4031_CR15","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126:1763\u20138.","journal-title":"Anesth Analg"},{"key":"4031_CR16","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics"},{"key":"4031_CR17","doi-asserted-by":"crossref","unstructured":"Leiherer A, Muendlein A, Mink S, Mader A, Saely CH, Festa A et al. Machine learning approach to metabolomic data predicts type 2 diabetes mellitus incidence. Int J Mol Sci. 2024;25.","DOI":"10.3390\/ijms25105331"},{"key":"4031_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.6026\/97320630002005","volume":"2","author":"L Kumar","year":"2007","unstructured":"Kumar L. Mfuzz: a software package for soft clustering of microarray data. Bioinformation. 2007;2:5\u20137.","journal-title":"Bioinformation"},{"key":"4031_CR19","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35:4200\u20132.","journal-title":"Bioinformatics"},{"key":"4031_CR20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s11033-024-09406-8","volume":"51","author":"N Zhu","year":"2024","unstructured":"Zhu N, Hou J, Si J, Yang N, Chen B, Wei X, et al. SIRT1 and ZNF350 as novel biomarkers for osteoporosis: a bioinformatics analysis and experimental validation. Mol Biol Rep. 2024;51:530.","journal-title":"Mol Biol Rep"},{"key":"4031_CR21","doi-asserted-by":"publisher","first-page":"871008","DOI":"10.3389\/fimmu.2022.871008","volume":"13","author":"X Hu","year":"2022","unstructured":"Hu X, Ni S, Zhao K, Qian J, Duan Y. Bioinformatics-Led discovery of osteoarthritis biomarkers and inflammatory infiltrates. Front Immunol. 2022;13:871008.","journal-title":"Front Immunol"},{"key":"4031_CR22","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1038\/s41598-023-29058-1","volume":"13","author":"B Haghighi","year":"2023","unstructured":"Haghighi B, Horng H, Noel PB, Cohen EA, Pantalone L, Vachani A, et al. Radiomic phenotyping of the lung parenchyma in a lung cancer screening cohort. Sci Rep. 2023;13:2040.","journal-title":"Sci Rep"},{"key":"4031_CR23","doi-asserted-by":"publisher","first-page":"2421231","DOI":"10.1080\/21505594.2024.2421231","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Cao W, Wang S, Zhang L, Li X, Zhang Z, et al. Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma. Virulence. 2024;15:2421231.","journal-title":"Virulence"},{"key":"4031_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/labmed\/lmad081","volume":"55","author":"AL AA","year":"2024","unstructured":"AA AL, Rizk SK, Khamis AK, Kasemy ZA, Habieb MSE. Utility of a MicroRNA panel in diagnosis and prognosis of hepatitis C-associated hepatocellular carcinoma. Lab Med. 2024;55:310\u20139.","journal-title":"Lab Med"},{"key":"4031_CR25","doi-asserted-by":"crossref","unstructured":"Petrovic A, Stancl P, Grskovic P, Hancic S, Karlic R, Gasparov S et al. Gene expression aberrations in Alcohol-Associated hepatocellular carcinoma. Int J Mol Sci. 2024;25.","DOI":"10.3390\/ijms251910558"},{"key":"4031_CR26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.jhep.2021.01.028","volume":"74","author":"L de la Conde","year":"2021","unstructured":"de la Conde L, Garcia-Ruiz C, Vallejo C, Baulies A, Nunez S, Monte MJ, et al. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway. J Hepatol. 2021;74:1429\u201341.","journal-title":"J Hepatol"},{"key":"4031_CR27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12032-024-02450-1","volume":"41","author":"NA Abou Madawi","year":"2024","unstructured":"Abou Madawi NA, Darwish ZE, Omar EM. Targeted gene therapy for cancer: the impact of MicroRNA multipotentiality. Med Oncol. 2024;41:214.","journal-title":"Med Oncol"},{"key":"4031_CR28","doi-asserted-by":"crossref","unstructured":"Force M, Park G, Chalikonda D, Roth C, Cohen M, Halegoua-DeMarzio D et al. Alpha-Fetoprotein (AFP) and AFP-L3 is most useful in detection of recurrence of hepatocellular carcinoma in patients after tumor ablation and with low AFP level. Viruses. 2022;14.","DOI":"10.3390\/v14040775"},{"key":"4031_CR29","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s12029-020-00486-w","volume":"51","author":"F Ozdemir","year":"2020","unstructured":"Ozdemir F, Baskiran A. The importance of AFP in liver transplantation for HCC. J Gastrointest Cancer. 2020;51:1127\u201332.","journal-title":"J Gastrointest Cancer"},{"key":"4031_CR30","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.jhep.2023.08.020","volume":"79","author":"JS Norman","year":"2023","unstructured":"Norman JS, Li PJ, Kotwani P, Shui AM, Yao F, Mehta N. AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation. J Hepatol. 2023;79:1469\u201377.","journal-title":"J Hepatol"},{"key":"4031_CR31","doi-asserted-by":"publisher","first-page":"102185","DOI":"10.1016\/j.tranon.2024.102185","volume":"51","author":"R Zhang","year":"2025","unstructured":"Zhang R, Chen W, Peng X, Zhang Z, Yang S, Zhong L. Prognostic significance of combined PCPE-1 and alpha-fetoprotein for hepatocellular carcinoma. Transl Oncol. 2025;51:102185.","journal-title":"Transl Oncol"},{"key":"4031_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12672-025-02295-8","volume":"16","author":"F Chen","year":"2025","unstructured":"Chen F, Cai Y, Zhou J. Relationship between retinol metabolism and hepatocellular carcinoma: a comprehensive analysis of Mendelian randomization, prognostic characteristic and experiment. Discov Oncol. 2025;16:513.","journal-title":"Discov Oncol"},{"key":"4031_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/hepr.13432","volume":"50","author":"YH Zhu","year":"2020","unstructured":"Zhu YH, Li JB, Wu RY, Yu Y, Li X, Li ZL, et al. Clinical significance and function of RDH16 as a tumor-suppressing gene in hepatocellular carcinoma. Hepatol Res. 2020;50:110\u201320.","journal-title":"Hepatol Res"},{"key":"4031_CR34","doi-asserted-by":"publisher","first-page":"26075","DOI":"10.1021\/acsomega.4c01496","volume":"9","author":"A Mestareehi","year":"2024","unstructured":"Mestareehi A. Global gene expression profiling and bioinformatics analysis reveal downregulated biomarkers as potential indicators for hepatocellular carcinoma. ACS Omega. 2024;9:26075\u201396.","journal-title":"ACS Omega"},{"key":"4031_CR35","doi-asserted-by":"crossref","unstructured":"Karunakara SH, Puttahanumantharayappa LD, Sannappa Gowda NG, Shiragannavar VD, Santhekadur PK. Novel insights into MEG3\/miR664a-3p\/ADH4 Axis and its possible role in hepatocellular carcinoma from an in Silico perspective. Genes (Basel). 2022;13.","DOI":"10.3390\/genes13122254"},{"key":"4031_CR36","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1038\/s41598-024-59062-y","volume":"14","author":"Y Lu","year":"2024","unstructured":"Lu Y, Wen W, Huang Q, Duan N, Li M, Zhang K, et al. Development and experimental validation of an energy metabolism-related gene signature for diagnosing of osteoporosis. Sci Rep. 2024;14:8153.","journal-title":"Sci Rep"},{"key":"4031_CR37","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1186\/s12885-024-12781-x","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu Y, Yu J, An X, Rao H, Qiu Z, Ke J, et al. TSA attenuates the progression of c-Myc-driven hepatocarcinogenesis by pAKT-ADH4 pathway. BMC Cancer. 2024;24:1049.","journal-title":"BMC Cancer"},{"key":"4031_CR38","doi-asserted-by":"publisher","first-page":"156267","DOI":"10.1016\/j.metabol.2025.156267","volume":"168","author":"K Xu","year":"2025","unstructured":"Xu K, Wu T, Li X, Zhang X, Liu X, Ma S, et al. ADH1C maintains the homeostasis of metabolic microenvironment to inhibit steatotic hepatocellular carcinoma. Metabolism. 2025;168:156267.","journal-title":"Metabolism"},{"key":"4031_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1055\/a-2184-8945","volume":"56","author":"Y Yu","year":"2024","unstructured":"Yu Y, Liu Y. LncRNA LINC01339 hinders the development of Wilms\u2019 tumor via MiR-135b-3p\/ADH1C Axis. Horm Metab Res. 2024;56:244\u201354.","journal-title":"Horm Metab Res"},{"key":"4031_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12920-023-01488-w","volume":"16","author":"MA Horaira","year":"2023","unstructured":"Horaira MA, Islam MA, Kibria MK, Alam MJ, Kabir SR, Mollah MNH. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents. BMC Med Genomics. 2023;16:64.","journal-title":"BMC Med Genomics"},{"key":"4031_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12967-020-02229-8","volume":"18","author":"CH Jiang","year":"2020","unstructured":"Jiang CH, Yuan X, Li JF, Xie YF, Zhang AZ, Wang XL, et al. Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma. J Transl Med. 2020;18:40.","journal-title":"J Transl Med"},{"key":"4031_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12935-023-03097-0","volume":"23","author":"D Li","year":"2023","unstructured":"Li D, Lin X, Li J, Liu X, Zhang F, Tang W, et al. Eleven metabolism\u2013related genes composed of Stard5 predict prognosis and contribute to EMT phenotype in HCC. Cancer Cell Int. 2023;23:277.","journal-title":"Cancer Cell Int"},{"key":"4031_CR43","first-page":"39","volume":"53","author":"EA Kamenets","year":"2020","unstructured":"Kamenets EA, Gusarova EA, Milovanova NV, Itkis YS, Strokova TV, Melikyan MA, et al. Hepatic glycogen synthase (GYS2) deficiency: seven novel patients and seven novel variants. JIMD Rep. 2020;53:39\u201344.","journal-title":"JIMD Rep"},{"key":"4031_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12933-024-02119-z","volume":"23","author":"W Chen","year":"2024","unstructured":"Chen W, Wu X, Hu J, Liu X, Guo Z, Wu J, et al. The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1\/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7. Cardiovasc Diabetol. 2024;23:21.","journal-title":"Cardiovasc Diabetol"},{"key":"4031_CR45","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.3934\/mbe.2020186","volume":"17","author":"TZ Sun","year":"2020","unstructured":"Sun TZ, Mu D. Multi-scale modeling identifies the role of p53-Gys2 negative feedback loop in cellular homeostasis. Math Biosci Eng. 2020;17:3260\u201373.","journal-title":"Math Biosci Eng"},{"key":"4031_CR46","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","volume":"86","author":"GP Nagaraju","year":"2022","unstructured":"Nagaraju GP, Dariya B, Kasa P, Peela S, El-Rayes BF. Epigenetics in hepatocellular carcinoma. Semin Cancer Biol. 2022;86:622\u201332.","journal-title":"Semin Cancer Biol"},{"key":"4031_CR47","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/j.1530-0277.2006.00107.x","volume":"30","author":"LO Dannenberg","year":"2006","unstructured":"Dannenberg LO, Chen HJ, Tian H, Edenberg HJ. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation. Alcohol Clin Exp Res. 2006;30:928\u201337.","journal-title":"Alcohol Clin Exp Res"},{"key":"4031_CR48","doi-asserted-by":"publisher","first-page":"175736","DOI":"10.1016\/j.ejphar.2023.175736","volume":"950","author":"L Le","year":"2023","unstructured":"Le L, Qipeng W, Chunmeng M, Hasnat M, Luyong Z, Zhenzhou J, et al. 5-Azacytidine promotes HCC cell metastasis by up-regulating RDH16 expression. Eur J Pharmacol. 2023;950:175736.","journal-title":"Eur J Pharmacol"},{"key":"4031_CR49","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.21037\/tcr-2025-546","volume":"14","author":"S Shi","year":"2025","unstructured":"Shi S, Liang W, Qie Y, Wu R, Zhu Y. Investigation of mitochondrial DNA methylation-related prognostic biomarkers in hepatocellular carcinoma using the Cancer genome atlas (TCGA) database. Transl Cancer Res. 2025;14:2095\u2013112.","journal-title":"Transl Cancer Res"},{"key":"4031_CR50","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1158\/0008-5472.CAN-18-2357","volume":"79","author":"SL Chen","year":"2019","unstructured":"Chen SL, Zhang CZ, Liu LL, Lu SX, Pan YH, Wang CH, et al. A GYS2\/p53 negative feedback loop restricts tumor growth in HBV-Related hepatocellular carcinoma. Cancer Res. 2019;79:534\u201345.","journal-title":"Cancer Res"},{"key":"4031_CR51","doi-asserted-by":"publisher","first-page":"8534","DOI":"10.1038\/srep08534","volume":"5","author":"D Yu","year":"2015","unstructured":"Yu D, Green B, Marrone A, Guo Y, Kadlubar S, Lin D, et al. Suppression of CYP2C9 by MicroRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma. Sci Rep. 2015;5:8534.","journal-title":"Sci Rep"},{"key":"4031_CR52","doi-asserted-by":"crossref","unstructured":"Pecoraro A, Pagano M, Russo G, Russo A. Ribosome biogenesis and cancer: overview on ribosomal proteins. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22115496"},{"key":"4031_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bcp.2018.11.014","volume":"159","author":"F Catez","year":"2019","unstructured":"Catez F, Dalla Venezia N, Marcel V, Zorbas C, Lafontaine DLJ, Diaz JJ. Ribosome biogenesis: an emerging druggable pathway for cancer therapeutics. Biochem Pharmacol. 2019;159:74\u201381.","journal-title":"Biochem Pharmacol"},{"key":"4031_CR54","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/MBC.0000000000000720","volume":"29","author":"EM Conway","year":"2018","unstructured":"Conway EM. Complement-coagulation connections. Blood Coagul Fibrinolysis. 2018;29:243\u201351.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"4031_CR55","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","volume":"133","author":"SP Jackson","year":"2019","unstructured":"Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood. 2019;133:906\u201318.","journal-title":"Blood"},{"key":"4031_CR56","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/MOH.0000000000000605","volume":"27","author":"S Oncul","year":"2020","unstructured":"Oncul S, Afshar-Kharghan V. The interaction between the complement system and hemostatic factors. Curr Opin Hematol. 2020;27:341\u201352.","journal-title":"Curr Opin Hematol"},{"key":"4031_CR57","doi-asserted-by":"publisher","first-page":"173121","DOI":"10.1016\/j.ejphar.2020.173121","volume":"879","author":"J Zhang","year":"2020","unstructured":"Zhang J, Chen M, Zhao Y, Xiong H, Sneh T, Fan Y, et al. Complement and coagulation cascades pathway correlates with chemosensitivity and overall survival in patients with soft tissue sarcoma. Eur J Pharmacol. 2020;879:173121.","journal-title":"Eur J Pharmacol"},{"key":"4031_CR58","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1038\/s41598-021-82733-z","volume":"11","author":"L Youssef","year":"2021","unstructured":"Youssef L, Miranda J, Blasco M, Paules C, Crovetto F, Palomo M, et al. Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics. Sci Rep. 2021;11:3048.","journal-title":"Sci Rep"},{"key":"4031_CR59","doi-asserted-by":"publisher","first-page":"e32542","DOI":"10.1097\/MD.0000000000032542","volume":"102","author":"W Ye","year":"2023","unstructured":"Ye W, Li X. Development of fatty acid metabolism-related models in lung adenocarcinomaa. Rev Med (Baltimore). 2023;102:e32542.","journal-title":"Rev Med (Baltimore)"},{"key":"4031_CR60","doi-asserted-by":"publisher","first-page":"1065927","DOI":"10.3389\/fimmu.2022.1065927","volume":"13","author":"S Yang","year":"2022","unstructured":"Yang S, Sun B, Li W, Yang H, Li N, Zhang X. Fatty acid metabolism is related to the immune microenvironment changes of gastric cancer and RGS2 is a new tumor biomarker. Front Immunol. 2022;13:1065927.","journal-title":"Front Immunol"},{"key":"4031_CR61","doi-asserted-by":"publisher","first-page":"17847","DOI":"10.18632\/aging.203288","volume":"13","author":"D He","year":"2021","unstructured":"He D, Cai L, Huang W, Weng Q, Lin X, You M, et al. Prognostic value of fatty acid metabolism-related genes in patients with hepatocellular carcinoma. Aging. 2021;13:17847\u201363.","journal-title":"Aging"},{"key":"4031_CR62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie E, Schulze A, Zechner R, Walther TC, Farese RV. Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18:153\u201361.","journal-title":"Cell Metab"},{"key":"4031_CR63","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41568-021-00388-4","volume":"21","author":"AJ Hoy","year":"2021","unstructured":"Hoy AJ, Nagarajan SR, Butler LM. Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat Rev Cancer. 2021;21:753\u201366.","journal-title":"Nat Rev Cancer"},{"key":"4031_CR64","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","volume":"42","author":"X Yang","year":"2024","unstructured":"Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, et al. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 2024;42:180\u201397.","journal-title":"Cancer Cell"},{"key":"4031_CR65","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.32740","volume":"77","author":"R Donne","year":"2023","unstructured":"Donne R, Lujambio A. The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma. Hepatology. 2023;77:1773\u201396.","journal-title":"Hepatology"},{"key":"4031_CR66","doi-asserted-by":"crossref","unstructured":"Liu H, Zhu Y, Ng KT, Lo CM, Man K. The landscape of aberrant alternative splicing events in steatotic liver graft post transplantation via Transcriptome-Wide analysis. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms24098216"},{"key":"4031_CR67","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.7150\/jca.92185","volume":"15","author":"S Lin","year":"2024","unstructured":"Lin S, Li D, Yang Y, Yu M, Zhao R, Li J, et al. Single-cell RNA-Seq elucidates the crosstalk between Cancer stem cells and the tumor microenvironment in hepatocellular carcinoma. J Cancer. 2024;15:1093\u2013109.","journal-title":"J Cancer"},{"key":"4031_CR68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ol.2022.13589","volume":"25","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Jiang HH, Wang ZY, Zhai B, Lin MB. Alcohol dehydrogenase 4 is a TP53-associated gene signature for the prediction of prognosis in hepatocellular carcinoma. Oncol Lett. 2023;25:3.","journal-title":"Oncol Lett"},{"key":"4031_CR69","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12859-023-05220-4","volume":"24","author":"WX Yang","year":"2023","unstructured":"Yang WX, Gao HW, Cui JB, Zhang AA, Wang FF, Xie JQ, et al. Development and validation of a coagulation-related genes prognostic model for hepatocellular carcinoma. BMC Bioinformatics. 2023;24:89.","journal-title":"BMC Bioinformatics"},{"key":"4031_CR70","doi-asserted-by":"publisher","first-page":"599475","DOI":"10.3389\/fmolb.2020.599475","volume":"7","author":"D Zhang","year":"2020","unstructured":"Zhang D, Qian C, Wei H, Qian X. Identification of the prognostic value of tumor Microenvironment-Related genes in esophageal squamous cell carcinoma. Front Mol Biosci. 2020;7:599475.","journal-title":"Front Mol Biosci"},{"key":"4031_CR71","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s40001-023-01535-3","volume":"28","author":"J Zhao","year":"2023","unstructured":"Zhao J, Luo Z, Fu R, Zhou J, Chen S, Wang J, et al. Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma. Eur J Med Res. 2023;28:571.","journal-title":"Eur J Med Res"},{"key":"4031_CR72","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.pharmthera.2014.05.011","volume":"144","author":"P Shahabi","year":"2014","unstructured":"Shahabi P, Siest G, Meyer UA, Visvikis-Siest S. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders. Pharmacol Ther. 2014;144:134\u201361.","journal-title":"Pharmacol Ther"},{"key":"4031_CR73","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1124\/jpet.118.255018","volume":"368","author":"DG Hu","year":"2019","unstructured":"Hu DG, Marri S, McKinnon RA, Mackenzie PI, Meech R. Deregulation of the genes that are involved in drug absorption, distribution, metabolism, and excretion in hepatocellular carcinoma. J Pharmacol Exp Ther. 2019;368:363\u201381.","journal-title":"J Pharmacol Exp Ther"},{"key":"4031_CR74","doi-asserted-by":"crossref","unstructured":"Zimta AA, Cenariu D, Irimie A, Magdo L, Nabavi SM, Atanasov AG et al. The role of Nrf2 activity in Cancer development and progression. Cancers (Basel). 2019;11.","DOI":"10.3390\/cancers11111755"},{"key":"4031_CR75","doi-asserted-by":"publisher","first-page":"625472","DOI":"10.3389\/fimmu.2021.625472","volume":"12","author":"J Tang","year":"2021","unstructured":"Tang J, Yan Z, Feng Q, Yu L, Wang H. The roles of neutrophils in the pathogenesis of liver diseases. Front Immunol. 2021;12:625472.","journal-title":"Front Immunol"},{"key":"4031_CR76","doi-asserted-by":"publisher","first-page":"1054753","DOI":"10.3389\/fimmu.2022.1054753","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yan P, Bin Y, Qin X, Wu Z. Neutrophil extracellular traps and complications of liver transplantation. Front Immunol. 2022;13:1054753.","journal-title":"Front Immunol"},{"key":"4031_CR77","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2024.02.015","volume":"543","author":"MJ Alam","year":"2024","unstructured":"Alam MJ, Rahman MH, Hossain MA, Hoque MR, Aktaruzzaman M. Bioinformatics and systems biology approaches to identify the synergistic effects of alcohol use disorder on the progression of neurological diseases. Neuroscience. 2024;543:65\u201382.","journal-title":"Neuroscience"},{"key":"4031_CR78","first-page":"1517","volume":"126","author":"SW Shan","year":"2013","unstructured":"Shan SW, Fang L, Shatseva T, Rutnam ZJ, Yang X, Du W, et al. Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. J Cell Sci. 2013;126:1517\u201330.","journal-title":"J Cell Sci"},{"key":"4031_CR79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.33594\/000000118","volume":"53","author":"S Zhao","year":"2019","unstructured":"Zhao S, Li J, Zhang G, Wang Q, Wu C, Zhang Q, et al. Exosomal miR-451a functions as a tumor suppressor in hepatocellular carcinoma by targeting LPIN1. Cell Physiol Biochem. 2019;53:19\u201335.","journal-title":"Cell Physiol Biochem"},{"key":"4031_CR80","first-page":"233","volume":"75","author":"Y Liu","year":"2023","unstructured":"Liu Y, Cheng R, Wu Y, Liu C, Liu Y, Chang Q, et al. Tumor-Promoting effects of Microrna-421\/4-Aminobutyrate aminotransferase Axis in hepatocellular carcinoma. Rev Invest Clin. 2023;75:233\u201348.","journal-title":"Rev Invest Clin"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04031-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:03:35Z","timestamp":1751357015000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04031-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4031"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04031-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involving human participants was reviewed and approved by the ethics committee of the First Affiliated Hospital of Kunming Medical University [(2023) Ethics L No. 205]. The patients\/participants provided written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}